Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group
- 1 June 2010
- journal article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 10 (3), 230-237
- https://doi.org/10.3816/cbc.2010.n.031
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) studyBritish Journal of Cancer, 2008
- Molecular profiling including epidermal growth factor receptor and p21 expression in high-risk breast cancer patients as indicators of outcomeAnnals of Oncology, 2008
- Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialBreast Cancer Research and Treatment, 2008
- A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancerBreast Cancer Research and Treatment, 2008
- Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 TrialJournal of Clinical Oncology, 2007
- Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast CancerClinical Cancer Research, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III studyBritish Journal of Cancer, 2006
- A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinomaCancer, 2000
- Tissue preparation for immunocytochemistry.Journal of Clinical Pathology, 1997